SWOT Analysis for Supriya Lifescience Ltd.

30 Day SMA crossing over 200 Day SMA, and current price greater than open
Strong Momentum: Price above short, medium and long term moving averages
Consistent Highest Return Stocks over Five Years - Nifty500
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over 1 Year
Company with high TTM EPS Growth
Stocks whose current price is 20% higher than week low, and more than previous close
Expensive Performers (DVM)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Good quarterly growth in the recent results
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Company with No Debt
Increasing Revenue every Quarter for the past 4 Quarters
Increasing profits every quarter for the past 4 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Book Value per share Improving for last 2 years
Company with Zero Promoter Pledge
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Highest Recovery from 52 Week Low
RSI indicating price strength
Biggest Price Gainers from Open
Top Gainers
Stocks Outperforming their Industry Price Change in the Quarter

Companies with growing costs YoY for long term projects
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Declining Net Cash Flow : Companies not able to generate net cash
Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV

Brokers upgraded recommendation or target price in the past three months
Mutual Funds Increased Shareholding in Past Month
FII / FPI or Institutions increasing their shareholding
MFs increased their shareholding last quarter

Insiders sold stocks

High Piotroski Score - Companies with strong financials
High Piotroski Score with High Return on Equity (ROE) and EPS Growth
Expensive Performers (DVM)
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Supriya Lifescience Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats